These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
133 related items for PubMed ID: 8500531
1. Mouse Crry/p65 is a regulator of the alternative pathway of complement activation. Foley S, Li B, Dehoff M, Molina H, Holers VM. Eur J Immunol; 1993 Jun; 23(6):1381-4. PubMed ID: 8500531 [Abstract] [Full Text] [Related]
3. Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein. Kim YU, Kinoshita T, Molina H, Hourcade D, Seya T, Wagner LM, Holers VM. J Exp Med; 1995 Jan 01; 181(1):151-9. PubMed ID: 7528766 [Abstract] [Full Text] [Related]
4. Blockade of antibody-induced glomerulonephritis with Crry-Ig, a soluble murine complement inhibitor. Quigg RJ, Kozono Y, Berthiaume D, Lim A, Salant DJ, Weinfeld A, Griffin P, Kremmer E, Holers VM. J Immunol; 1998 May 01; 160(9):4553-60. PubMed ID: 9574562 [Abstract] [Full Text] [Related]
6. CR2 is a complement activator and the covalent binding site for C3 during alternative pathway activation by Raji cells. Mold C, Nemerow GR, Bradt BM, Cooper NR. J Immunol; 1988 Mar 15; 140(6):1923-9. PubMed ID: 2831273 [Abstract] [Full Text] [Related]
8. Unrestricted C3 activation occurs in Crry-deficient kidneys and rapidly leads to chronic renal failure. Bao L, Wang Y, Chang A, Minto AW, Zhou J, Kang H, Haas M, Quigg RJ. J Am Soc Nephrol; 2007 Mar 15; 18(3):811-22. PubMed ID: 17229915 [Abstract] [Full Text] [Related]
12. Quantitative analysis of membrane cofactor protein (MCP) of complement. High expression of MCP on human leukemia cell lines, which is down-regulated during cell differentiation. Seya T, Hara T, Matsumoto M, Akedo H. J Immunol; 1990 Jul 01; 145(1):238-45. PubMed ID: 1694203 [Abstract] [Full Text] [Related]
18. Crry/p65, a membrane complement regulatory protein, has costimulatory properties on mouse T cells. Fernández-Centeno E, de Ojeda G, Rojo JM, Portolés P. J Immunol; 2000 May 01; 164(9):4533-42. PubMed ID: 10779754 [Abstract] [Full Text] [Related]
19. Localization of classical and alternative pathway regulatory activity within the decay-accelerating factor. Brodbeck WG, Liu D, Sperry J, Mold C, Medof ME. J Immunol; 1996 Apr 01; 156(7):2528-33. PubMed ID: 8786315 [Abstract] [Full Text] [Related]